Keya Medical Selected in Top 100 Medical Companies of the Future

December 20, 2019

Keya Medical is recognized in the Top 100 Medical companies by VCBeat

The Future Medical 100 Annual Conference was held Dec. 20, 2019 in Beijing Jiuhua Villa. Keya Medical was among the companies listed on the Top 100 List, and DEEPVESSEL FFR made the list of the Top 5 FFR Products in China.

VCBeat Research (VBR) has tracked and researched new medical technologies over the past five years and reported on innovation in the healthcare industry. The Top 100 Future Medical Companies list includes companies that are supporting innovation in healthcare.


DEEPVESSEL FFR received EU CE certification in Aug. 2018. Its intelligent imaging platform has entered more than ten countries in Europe and Southeast Asia. DEEPVESSEL FFR is also the first coronary AI product to enter the approval channel of the National Drug Administration (NMPA) for Class III software medical devices. It is expected that DEEPVESSEL FFR will be the first Class III AI software medical device in China to receive regulatory approval in 2020.